{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:01:35Z","timestamp":1793275295876,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["1559156"],"award-info":[{"award-number":["1559156"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.nbd.2020.104979","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T21:10:24Z","timestamp":1592946624000},"page":"104979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming"],"prefix":"10.1016","volume":"143","author":[{"given":"Haruo","family":"Nishijima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1903-1766","authenticated-orcid":false,"given":"Fumiaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9025-2548","authenticated-orcid":false,"given":"Motohiro","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Kon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104979_bb0005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104979_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2020.104979_bb0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson\u2019s disease","volume":"132","author":"Bastide","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2020.104979_bb0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/1531-8249(200005)47:5<655::AID-ANA16>3.0.CO;2-#","article-title":"Levodopa-induced dyskinesias in Parkinson\u2019s disease: is sensitization reversible?","volume":"47","author":"Bejjani","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104979_bb0030","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","article-title":"Pathophysiology of levodopa-induced dyskinesia: potential for new therapies","volume":"2","author":"Bezard","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-4159.2011.07376.x","article-title":"Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels","volume":"118","author":"Bido","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104979_bb0040","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/brain\/124.3.546","article-title":"Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey","volume":"124","author":"Boraud","year":"2001","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2020.104979_bb0045","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104979_bb0050","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1046\/j.1460-9568.2000.00089.x","article-title":"Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats","volume":"12","author":"Bordet","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0055","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.neuron.2015.08.022","article-title":"Loss of Striatonigral GABAergic presynaptic inhibition enables motor sensitization in parkinsonian mice","volume":"87","author":"Borgkvist","year":"2015","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2020.104979_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.conb.2017.10.021","article-title":"Synaptic plasticity may underlie l-DOPA induced dyskinesia","volume":"48","author":"Borgkvist","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2020.104979_bb0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00702-004-0251-7","article-title":"Levodopa-induced dyskinesia in Parkinson\u2019s disease","volume":"112","author":"Brotchie","year":"2005","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2020.104979_bb0070","article-title":"Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity?","volume":"47","author":"Calabresi","year":"2000","journal-title":"Ann Neurol."},{"key":"10.1016\/j.nbd.2020.104979_bb0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tins.2007.03.005","article-title":"Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia","volume":"30","author":"Cenci","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.2006.04124.x","article-title":"Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia","volume":"99","author":"Cenci","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104979_bb0085","first-page":"2694","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0090","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1523\/JNEUROSCI.0676-04.2004","article-title":"Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease","volume":"24","author":"Corvol","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0100","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJM200006083422304","article-title":"Long-term follow-up of unilateral pallidotomy in advanced Parkinson\u2019s disease","volume":"342","author":"Fine","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2020.104979_bb0105","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/brain\/awh290","article-title":"Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson\u2019s disease: implications for dyskinesias","volume":"127","author":"de la Fuente-Fernandez","year":"2004","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2020.104979_bb0110","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science."},{"key":"10.1016\/j.nbd.2020.104979_bb0115","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1523\/JNEUROSCI.22-12-05042.2002","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1\/2\/MAP kinase","volume":"22","author":"Gerfen","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0120","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S1471-1931(00)00027-6","article-title":"Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis","volume":"23","author":"Graybiel","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1699-0463.1988.tb05320.x","article-title":"Some new, simple and efficient stereological methods and their use in pathological research and diagnosis","volume":"96","author":"Gundersen","year":"1988","journal-title":"APMIS."},{"key":"10.1016\/j.nbd.2020.104979_bb0130","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1124\/jpet.106.110429","article-title":"In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\\ increased motor disability","volume":"319","author":"Iravani","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2020.104979_bb0135","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.58.suppl_1.S1","article-title":"Pharmacology of dopamine agonists in the treatment of Parkinson\u2019s disease","volume":"58","author":"Jenner","year":"2002","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2020.104979_bb0140","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1471-4159.2001.00184.x","article-title":"Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation","volume":"76","author":"Kannari","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104979_bb0145","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJM199710093371503","article-title":"Posteroventral medial pallidotomy in advanced Parkinson\u2019s disease","volume":"337","author":"Lang","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2020.104979_bb0150","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00702-017-1837-1","article-title":"Serotonergic targets for the treatment of L-DOPA-induced dyskinesia","volume":"125","author":"Lanza","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2020.104979_bb0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tips.2005.06.007","article-title":"New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity","volume":"26","author":"Linazasoro","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2020.104979_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/bph.12894","article-title":"Side effect profile of 5-HT treatments for Parkinson\u2019s disease and L-DOPA-induced dyskinesia in rats","volume":"172","author":"Lindenbach","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2020.104979_bb0165","first-page":"S141","article-title":"Neuronal recordings in Parkinson\u2019s disease patients with dyskinesias induced by apomorphine","volume":"47","author":"Lozano","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104979_bb0170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0175","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(82)92797-0","article-title":"Basal ganglia disease","volume":"2","author":"Marsden","year":"1982","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2020.104979_bb0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2007.04456.x","article-title":"Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson\u2019s disease","volume":"101","author":"Mela","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104979_bb0185","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.nbd.2011.09.015","article-title":"In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels","volume":"45","author":"Mela","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104979_bb0190","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1046\/j.1460-9568.2003.02698.x","article-title":"Subtype switching of vesicular glutamate transporters at parallel fibre-Purkinje cell synapses in developing mouse cerebellum","volume":"17","author":"Miyazaki","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuroscience.2003.08.010","article-title":"Normalization of glutamate decarboxylase gene expression in the entopeduncular nucleus of rats with a unilateral 6-hydroxydopamine lesion correlates with increased GABAergic input following intermittent but not continuous levodopa","volume":"123","author":"Nielsen","year":"2004","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2020.104979_bb0200","first-page":"8626783","article-title":"Zonisamide enhances motor effects of levodopa, not of Apomorphine, in a rat model of Parkinson\u2019s disease","volume":"2018","author":"Nishijima","year":"2018","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.nbd.2020.104979_bb0205","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mds.27172","article-title":"Levodopa treatment and dendritic spine pathology","volume":"33","author":"Nishijima","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104979_bb0210","article-title":"Pathophysiology of levodopa-induced dyskinesias in Parkinson\u2019s disease: problems with the current model","volume":"47","author":"Obeso","year":"2000","journal-title":"Ann Neurol."},{"key":"10.1016\/j.nbd.2020.104979_bb0215","article-title":"Preventing levodopa-induced dyskinesias","volume":"47","author":"Olanow","year":"2000","journal-title":"Ann Neurol."},{"key":"10.1016\/j.nbd.2020.104979_bb0220","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/mds.26326","article-title":"Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity","volume":"30","author":"Paolone","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104979_bb0225","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/1531-8249(199911)46:5<732::AID-ANA8>3.0.CO;2-Q","article-title":"Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias","volume":"46","author":"Papa","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104979_bb0230","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0165-0173(94)00008-D","article-title":"Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res Brain Res Rev."},{"key":"10.1016\/j.nbd.2020.104979_bb0235","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1212\/01.wnl.0000242888.30755.5d","article-title":"Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study","volume":"67","author":"Pavese","year":"2006","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2020.104979_bb0240","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.nbd.2020.104979_bb0245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.104979_bb0250","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bmj.310.6979.575","article-title":"Drug treatment of Parkinson\u2019s disease","volume":"310","author":"Quinn","year":"1995","journal-title":"BMJ."},{"key":"10.1016\/j.nbd.2020.104979_bb0255","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cne.903500214","article-title":"Parvalbumin-containing GABAergic neurons in the basal ganglia output system of the rat","volume":"350","author":"Rajakumar","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2020.104979_bb0260","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.neuropharm.2008.06.002","article-title":"6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat","volume":"55","author":"Rangel-Barajas","year":"2008","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.nbd.2020.104979_bb0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2010.08.018","article-title":"L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V\/VI and increased GABA release in the substantia nigra reticulata","volume":"41","author":"Rangel-Barajas","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104979_bb0270","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2020.104979_bb0275","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","article-title":"Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats","volume":"10","author":"Tanaka","year":"1999","journal-title":"Neuroreport."},{"key":"10.1016\/j.nbd.2020.104979_bb0280","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1789.2004.00559.x","article-title":"Hypertrophy of medial globus pallidus and substantia nigra reticulata in 6-hydroxydopamine-lesioned rats treated with L-DOPA: implication for L-DOPA-induced dyskinesia in Parkinson\u2019s disease","volume":"24","author":"Tomiyama","year":"2004","journal-title":"Neuropathology."},{"key":"10.1016\/j.nbd.2020.104979_bb0285","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00702-018-1900-6","article-title":"Levodopa-induced dyskinesia: clinical features, incidence, and risk factors","volume":"125","author":"Tran","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2020.104979_bb0290","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.20091","article-title":"Long-term results of bilateral pallidal stimulation in Parkinson\u2019s disease","volume":"55","author":"Volkmann","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104979_bb0295","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainres.2006.09.027","article-title":"Subchronic administration of L-DOPA to adult rats with a unilateral 6-hydroxydopamine lesion of dopamine neurons results in a sensitization of enhanced GABA release in the substantia nigra, pars reticulata","volume":"1123","author":"Yamamoto","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.104979_bb0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eplepsyres.2006.05.017","article-title":"Effects of interleukin-1beta on hippocampal glutamate and GABA releases associated with Ca2+\u2212induced Ca2+ releasing systems","volume":"71","author":"Zhu","year":"2006","journal-title":"Epilepsy Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120302540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120302540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:21:01Z","timestamp":1760851261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120302540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":60,"alternative-id":["S0969996120302540"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104979","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104979"}}